Home
Conditions
Mosquito-Borne Diseases

Clinical trial condition

Mosquito-Borne Diseases

Explore clinical trials studying Mosquito-Borne Diseases. Study availability and eligibility vary by location and protocol.

1,584 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Mosquito-Borne Diseases trial results

Completed

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

NCT06408857

Conditions: Healthy Volunteers, Infections, Malaria, +5 more
Locations: JCRC-Joint Clinical Research Centre Kampala, Uganda

IDRC-Infectious Disease Research Collaboration, IDRC Tororo Hospital Station Road Tororo, Uganda

View Trial Details

Completed

Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure

NCT04706130

Conditions: Infections, Malaria, Malaria, Vivax, +5 more
Locations: Institut Pasteur du Cambodge Phnom Penh, Cambodia

View Trial Details

Completed

Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic Region

NCT07621848

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations: Kassala Advanced Diagnostic Center Kassala, Sudan

View Trial Details

Completed

A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

NCT05357560

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Medical Research Council Unit, Fajara Banjul, The Gambia

View Trial Details

Completed

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)

NCT07235033

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Novartis Investigative Site Abidjan, Côte d’Ivoire

Novartis Investigative Site Libreville, Gabon

Novartis Investigative Site Ahero, Kenya

View Trial Details

Completed

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

NCT04546633

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Novartis Investigative Site Banfora, Burkina Faso

Novartis Investigative Site Bobo-Dioulasso, Burkina Faso

Novartis Investigative Site Ouagadougou, Burkina Faso

Novartis Investigative Site Sabou, Burkina Faso

View Trial Details

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

NCT06558643

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Quotient Sciences Ruddington, Nottingham, United Kingdom

View Trial Details

Completed

Star Homes Project 2

NCT04529434

Conditions: Diarrhoea;Acute, Infections, Malaria, +5 more
Locations: CSK Research Solutions Dar Es Salaam, Mtwara, Tanzania

View Trial Details

Completed

Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria

NCT03503058

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Department of Internal Medicine, Universitas Indonesia Jakarta, Indonesia

Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology Jakarta, Indonesia

View Trial Details

Completed

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

NCT05052502

Conditions: Infections, Malaria, Malaria, Falciparum, +7 more
Locations: Division of Vector Born Diseases, Ministry of Health Bangkok, Thailand

View Trial Details

Mosquito-Borne Diseases

Mosquito-Borne Diseases trial results

Related conditions